Keebeck Wealth Management, LLC reports 25.43% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Keebeck Wealth Management, LLC
Latest Disclosed Ownership	15,805 shares
Latest Disclosed Value	$ 958,573

On May 14, 2026 - Keebeck Wealth Management, LLC filed a 13F-HR form disclosing ownership of 15,805 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $828,498 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 12,601 shares of Bristol-Myers Squibb Company. This represents a change in shares of 25.43% during the quarter. The current value of the position is $749,631 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-14	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	15,805	3,204	25.43	959	41.09	0.1078
2026-02-17	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	12,601	90	0.72	680	20.39	0.0784
2025-11-14	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	12,511	610	5.13	564	2.55	0.0667
2025-08-14	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	11,901	-322	-2.63	551	-26.17	0.0721
2025-05-15	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	12,223	-9,448	-43.60	745	-39.18	0.1100
2025-02-14	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,671	388	1.82	1,226	11.26	0.1767
2024-11-14	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,283	6	0.03	1,101	24.69	0.1595
2024-08-14	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,277	9,928	87.48	884	43.58	0.1296
2024-05-14	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	11,349	-855	-7.01	615	-1.76	0.0905
2024-02-14	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	12,204	-4,547	-27.14	626	-35.60	0.1033
2023-11-14	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	16,751	6,438	62.43	972	47.50	0.1693
2023-08-14	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,313	5,060	96.33	660	81.04	0.0906
2023-05-15	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	5,253	1,524	40.87	364	35.82	0.0587
2023-02-14	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	3,729	81	2.22	268	3.47	0.0471
2022-11-14	2022-09-30	13F	Bristol Myers Squibb Co Com	COM	110122108	3,648	-194	-5.05	259	-13.09	0.0499
2022-08-15	2022-06-30	13F	Bristol Myers Squibb Co Com	COM	110122108	3,842	0	0.00	298	5.30	0.0570
2022-05-16	2022-03-31	13F	Bristol Myers Squibb Co Com	COM	110122108	3,842	0	0.00	283	17.92	0.0469
2022-02-14	2021-12-31	13F	Bristol Myers Squibb Co Com	COM	110122108	3,842	-24,717	-86.55	240	-85.92	0.0428
2021-11-16	2021-09-30	13F	Bristol Myers Squibb Co Com	COM	110122108	28,559	-883	-3.00	1,704	-13.37	0.3360
2021-08-16	2021-06-30	13F	Bristol Myers Squibb Co Com	COM	110122108	29,442	25,000	562.81	1,967	595.05	0.2836
2021-05-13	2021-03-31	13F	Bristol Myers Squibb Co Com	COM	110122108	4,442	-7,454	-62.66	283	-61.96	0.0440
2021-02-16	2020-12-31	13F	Bristol Myers Squibb Co Com	COM	110122108	11,896	4,488	60.58	744	66.82	0.1295
2020-11-02	2020-09-30	13F	Bristol Myers Squibb Co Com	COM	110122108	7,408	-898	-10.81	446	-8.61	0.0921
2020-08-06	2020-06-30	13F	Bristol Myers Squibb Co Com	COM	110122108	8,306	8,306		488		0.1543
2020-05-14	2020-03-31	13F	Bristol Myers Squibb Co Com	COM	110122108	0	-2,790	-100.00	0	-100.00
2020-02-14	2019-12-31	13F	Bristol Myers Squibb Co Com	COM	110122108	2,790	2,790		178		0.0564

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.